These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 3731947)
21. Circadian bioperiodic response of mice bearing advanced L1210 leukemia to combination therapy with adriamycin and cyclophosphamide. Scheving LE; Burns ER; Pauly JE; Halberg F Cancer Res; 1980 May; 40(5):1511-5. PubMed ID: 7370988 [No Abstract] [Full Text] [Related]
22. Inhibitory effects of selenium on the growth of L1210 leukemic cells. Milner JA; Hsu CY Cancer Res; 1981 May; 41(5):1652-6. PubMed ID: 7214335 [TBL] [Abstract][Full Text] [Related]
23. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. III. Control of host resistance to drug-resistant L1210 sublines by H-2-linked and non-H-2-linked genes. Fuji H; Murakami M J Natl Cancer Inst; 1983 Jan; 70(1):119-25. PubMed ID: 6296515 [TBL] [Abstract][Full Text] [Related]
24. Cyclic adenosine 3':5'-monophosphate-dependent protein phosphorylation and the control of leukemia L1210 cell growth. Mednieks MI; Jungmann RA; DeWys WD Cancer Res; 1982 Jul; 42(7):2742-7. PubMed ID: 6282449 [TBL] [Abstract][Full Text] [Related]
25. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide. Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053 [TBL] [Abstract][Full Text] [Related]
26. Age-related changes in the activity of cerebral rhodanese in mice during the first four months of life. Sani M; Sebai H; Gadacha W; Boughattas NA; Reinberg A; Ben-Attia M Brain Dev; 2008 Apr; 30(4):279-86. PubMed ID: 17997247 [TBL] [Abstract][Full Text] [Related]
27. Circadian time-dependent differences in murine tolerance to the antihistaminic agent loratadine. Dridi D; Boughattas NA; Aouam K; Reinberg A; Ben Attia M Chronobiol Int; 2005; 22(3):499-514. PubMed ID: 16076650 [TBL] [Abstract][Full Text] [Related]
28. Seasonal modulation of the 8-and 24-hour rhythms of ondansetron tolerance in mice. Khedhaier A; Ben-Attia M; Gadacha W; Sani M; Reinberg A; Boughattas NA Chronobiol Int; 2007; 24(6):1199-212. PubMed ID: 18075807 [TBL] [Abstract][Full Text] [Related]
29. [Effect of ethyl-O-[N-(p-carboxyphenyl) carbamoyl]-mycophenolate against L1210 leukemia]. Kato T; Ota K Gan To Kagaku Ryoho; 1985 Dec; 12(12):2327-30. PubMed ID: 4073927 [TBL] [Abstract][Full Text] [Related]
30. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210. Góra-Tybor J; Robak T; Warzocha K; Grieb P Arch Immunol Ther Exp (Warsz); 1994; 42(1):39-42. PubMed ID: 7503633 [TBL] [Abstract][Full Text] [Related]
31. Relationship between circadian rhythm of vinorelbine toxicity and efficacy in P388-bearing mice. Filipski E; Amat S; Lemaigre G; Vincenti M; Breillout F; Lévi FA J Pharmacol Exp Ther; 1999 Apr; 289(1):231-5. PubMed ID: 10087009 [TBL] [Abstract][Full Text] [Related]
32. Separate mechanisms for procarbazine spermatotoxicity and anticancer activity. Horstman MG; Meadows GG; Yost GS Cancer Res; 1987 Mar; 47(6):1547-50. PubMed ID: 3815355 [TBL] [Abstract][Full Text] [Related]
33. Circadian rhythm in murine reticuloendothelial function. Szabó I; Kovats TG; Halberg F Chronobiologia; 1978; 5(2):137-43. PubMed ID: 679796 [TBL] [Abstract][Full Text] [Related]
34. Muscle aspartyl protease (cathepsin D) activity: detection using a chromophoric substrate and relation to wasting in DBA/2 mice implanted with leukemic L1210 tumor cells. Bolger GT; Jaramillo J Can J Physiol Pharmacol; 1996 Oct; 74(10):1141-8. PubMed ID: 9022834 [TBL] [Abstract][Full Text] [Related]
35. Strain-difference in circadian murine chronotolerance to the antidepressant drug nomifensine. Sothern RB; Halberg F; Nelson W Chronobiologia; 1979; 6(4):397-404. PubMed ID: 548248 [TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of L-canavanine against L1210 murine leukemia. Green MH; Brooks TL; Mendelsohn J; Howell SB Cancer Res; 1980 Mar; 40(3):535-7. PubMed ID: 7471074 [TBL] [Abstract][Full Text] [Related]
37. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia. Li LH; Wallace TL; Richard KA; Tracey DE Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of benzoporphyrin derivative, a photosensitizer, in selective destruction of leukemia cells using a murine tumor model. Jamieson C; Richter A; Levy JG Exp Hematol; 1993 May; 21(5):629-34. PubMed ID: 8513863 [TBL] [Abstract][Full Text] [Related]
39. Combined chronochemotherapy of L1210 leukemic mice using 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine, methylprednisolone and cis-diamminedichloroplatinum. Scheving LE; Burns ER; Halberg F; Pauly JE Chronobiologia; 1980; 7(1):33-40. PubMed ID: 7192203 [TBL] [Abstract][Full Text] [Related]
40. Effects of alpha-difluoromethylornithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice, and solid tumors induced by injection of hepatoma tissue culture cells in rats. Bartholeyns J; Koch-Weser J Cancer Res; 1981 Dec; 41(12 Pt 1):5158-61. PubMed ID: 6796266 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]